{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:47:25Z","timestamp":1792799245186,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02883"],"award-info":[{"award-number":["18H02883"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03008"],"award-info":[{"award-number":["21H03008"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The intra-tumoral heterogeneity of HER2 expression is associated with resistance to anti-HER2 therapy in HER2-positive gastric cancers (GCs). We previously reported that thrombospondin-4 (THBS4) is overexpressed in cancer-associated fibroblasts (CAFs) in the GC microenvironment and is associated with GC remodeling. To clarify the relationship between CAFs and the intra-tumoral heterogeneity of HER2 in GC, the effect of CAFs on HER2 expression was investigated in GC cells. Two HER2-positive GC cell lines (NCI-N87 and OE19) and two pairs of gastric CAFs were used. The effect of fibroblasts on HER2 expression in cancer cells was analyzed by immunohistochemical staining and reverse transcription-polymerase chain reaction. THBS4 siRNA was used for knockdown assays. The effects of Herceptin or gabapentin, a THBS4 receptor inhibitor, on subcutaneous tumors were examined in nude mice. CAFs and THBS4 recombinant significantly downregulated HER2 (ERBB2) expression in GC cells. THBS4 siRNA and gabapentin significantly inhibited the HER2-decreasing activity in CAFs. In vivo, CAFs suppress HER2 expression of subcutaneous GC tumors and induce Herceptin resistance. Gabapentin overcomes CAF-induced Herceptin resistance. THBS4 from CAFs downregulated HER2 (ERBB2) expression in GC cells. Thus, THBS4 receptor inhibitors may be useful in preventing the acquisition of resistance to anti-HER2 therapy.<\/jats:p>","DOI":"10.1093\/carcin\/bgaf064","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:33:54Z","timestamp":1759750434000},"source":"Crossref","is-referenced-by-count":3,"title":["Thrombospondin-4 from cancer-associated fibroblasts downregulates\n                    <i>ERBB2<\/i>\n                    expression in gastric cancer cells"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5958-7939","authenticated-orcid":false,"given":"Gen","family":"Tsujio","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-7228","authenticated-orcid":false,"given":"Masakazu","family":"Yashiro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canfeng","family":"Fan","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoka","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinano","family":"Nishikubo","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Kanei","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Maruo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]},{"name":"Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaichi","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine , 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2025102711570988200_bgaf064-B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jpm10010010","article-title":"HER2 heterogeneity in personalized therapy of gastro-oesophageal malignancies: an overview by different methodologies","volume":"10","author":"Ieni","year":"2020","journal-title":"J Pers Med"},{"key":"2025102711570988200_bgaf064-B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00428-018-2502-2","article-title":"Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutic management","volume":"474","author":"Ieni","year":"2019","journal-title":"Virchows Arch"},{"key":"2025102711570988200_bgaf064-B3","doi-asserted-by":"publisher","first-page":"153229","DOI":"10.1016\/j.prp.2020.153229","article-title":"Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer","volume":"216","author":"Zhang","year":"2020","journal-title":"Pathol Res Pract"},{"key":"2025102711570988200_bgaf064-B4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0140-6736(10)61121-x","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"2025102711570988200_bgaf064-B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/PAP.0b013e3182026d72","article-title":"HER2 testing in gastric cancer","volume":"18","author":"Albarello","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"2025102711570988200_bgaf064-B6","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.1038\/srep11634","article-title":"Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance","volume":"5","author":"Zuo","year":"2015","journal-title":"Sci Rep"},{"key":"2025102711570988200_bgaf064-B7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-016-0302-1","article-title":"A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K\/AKT signaling pathway","volume":"9","author":"Liu","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2025102711570988200_bgaf064-B8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s10120-013-0288-0","article-title":"Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection","volume":"17","author":"Oh","year":"2014","journal-title":"Gastric Cancer"},{"key":"2025102711570988200_bgaf064-B9","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3748\/wjg.v18.i19.2402","article-title":"Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis","volume":"18","author":"Dang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"2025102711570988200_bgaf064-B10","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3748\/wjg.v19.i21.3316","article-title":"Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population","volume":"19","author":"Fan","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2025102711570988200_bgaf064-B11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3748\/wjg.v19.i14.2171","article-title":"Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer","volume":"19","author":"He","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2025102711570988200_bgaf064-B12","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1245\/s10434-011-1695-2","article-title":"Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays","volume":"18","author":"Kim","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"2025102711570988200_bgaf064-B13","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1007\/s13277-014-1636-3","article-title":"Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature","volume":"35","author":"Liang","year":"2014","journal-title":"Tumour Biol"},{"key":"2025102711570988200_bgaf064-B14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"2025102711570988200_bgaf064-B15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"2025102711570988200_bgaf064-B16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","article-title":"Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance","volume":"18","author":"Fiori","year":"2019","journal-title":"Mol Cancer"},{"key":"2025102711570988200_bgaf064-B17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025102711570988200_bgaf064-B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci"},{"key":"2025102711570988200_bgaf064-B19","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1161\/atvbaha.115.305912","article-title":"Proangiogenic properties of Thrombospondin-4","volume":"35","author":"Muppala","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025102711570988200_bgaf064-B20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/modpathol.2011.99","article-title":"THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling","volume":"24","author":"F\u00f6rster","year":"2011","journal-title":"Mod Pathol"},{"key":"2025102711570988200_bgaf064-B21","doi-asserted-by":"publisher","first-page":"e0224727","DOI":"10.1371\/journal.pone.0224727","article-title":"The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer","volume":"14","author":"Kuroda","year":"2019","journal-title":"PLoS One"},{"key":"2025102711570988200_bgaf064-B22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00280-006-0337-z","article-title":"Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models","volume":"59","author":"Fujimoto-Ouchi","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"2025102711570988200_bgaf064-B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13104-019-4103-9","article-title":"High dose gabapentin does not alter tumor growth in mice but reduces arginase activity and increases superoxide dismutase, IL-6 and MCP-1 levels in Ehrlich ascites","volume":"12","author":"da Cunha Leal","year":"2019","journal-title":"BMC Res Notes"},{"key":"2025102711570988200_bgaf064-B24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00428-013-1468-3","article-title":"Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer","volume":"463","author":"Reed","year":"2013","journal-title":"Virchows Arch"},{"key":"2025102711570988200_bgaf064-B25","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1074\/jbc.270.6.2809","article-title":"Characterization of human thrombospondin-4","volume":"270","author":"Lawler","year":"1995","journal-title":"J Biol Chem"},{"key":"2025102711570988200_bgaf064-B26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0960-9822(93)90270-x","article-title":"Extracellular matrix: the thrombospondin family","volume":"3","author":"Adams","year":"1993","journal-title":"Curr Biol"},{"key":"2025102711570988200_bgaf064-B27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.matbio.2017.11.006","article-title":"Thrombospondin-4 in tissue remodeling","volume":"75\u201376","author":"Stenina-Adognravi","year":"2019","journal-title":"Matrix Biol"},{"key":"2025102711570988200_bgaf064-B28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-020-01812-7","article-title":"Thrombospondin 4\/integrin \u03b12\/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells","volume":"40","author":"Shi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2025102711570988200_bgaf064-B29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaf064\/64528477\/bgaf064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaf064\/64528477\/bgaf064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaf064\/64528477\/bgaf064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:57:13Z","timestamp":1761580633000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/doi\/10.1093\/carcin\/bgaf064\/8276629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgaf064","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9]]},"article-number":"bgaf064"}}